| IC2407X |
| PROSPECT SWETENHAMS BUSINESS RATIO : PHARMACEUTICAL MANUFACTURERS - UK - MAY 2004 |
![]() |
CLICK
TO BUY |
| Leapfrog the competition!
Click here to create your own direct marketing lists for this sector! |
![]() |
![]() |
This Business Ratio report brings you detailed financial profiles, analysis and comparison of the leading 124 limited companies actively trading in this industry sector in Great Britain.
You can use this information in a wide number of ways, including:
COMPANIES INCLUDED IN THIS REPORT
This Business Ratio report analyses, compares and contrasts the most recent financial details covering three or four years for the leading 124 companies in the industry. For comparison purposes, the base year is the most recent year for which the vast majority of companies have filed details. However, if firms have published more recent details, these are also included as a fourth year of accounts.
For each company, a full 3-year financial profile is provided, including details of its performance on 25 key ratios. The volume also ranks companies against each other on these performance factors, and league table rankings are provided for each. With these you can quickly and easily see how companies compare on performance in the base year.
The figures for all companies in the report are aggregated and analysed to bring you industry average profiles. These show clearly just how the upper part of the sector is performing, and indicate towards trends that may influence all players in the industry.
In addition, an industry overview reviews the findings of the report, highlighting major changes and drawing your attention to the best and worst performers.
The following companies are profiled by the report:
| PHARMACEUTICAL MANUFACTURERS AND DEVELOPERS | PHARMACEUTICAL MANUFACTURERS AND DEVELOPERS |
| 3m Health Care Ltd | Norton Healthcare Ltd |
| Aah Pharmaceuticals Ltd | Nova Laboratories Ltd |
| Aequus Research Ltd | Novartis Consumer Health UK Ltd |
| A-Life Ltd | Novartis Grimsby Ltd |
| Allergan Ltd | Novartis Pharmaceuticals UK Ltd |
| Alpharma Ltd | Novex Pharma Ltd |
| Amarin Corporation PLC | Obg Pharmaceuticals Ltd |
| Aspar Pharmaceuticals Ltd | Organon Laboratories Ltd |
| Aspen Pharmacare International Ltd | Osi Pharmaceuticals (UK) Ltd |
| Astrazeneca PLC | Patheon UK Ltd |
| Astrazeneca UK Ltd | Penn Pharmaceutical Services Ltd |
| Bard Pharmaceuticals Ltd | Perrigo UK Acquisition Ltd |
| Battle, Hayward & Bower, Ltd | Pfizer Ltd |
| Biofocus PLC | Pfizer Consumer Health Products Co. |
| Biorex Laboratories Ltd | Pharmacia Ltd |
| Boehringer Ingelheim Ltd | Pharmaserve Ltd |
| Bristol Laboratories Ltd | Phoenix Chemicals Ltd |
| Bristol-Myers Squibb Pharmaceuticals Ltd | Pierre Fabre Ltd |
| Britannia Pharmaceuticals Ltd | Powderject Pharmaceuticals Ltd |
| Cambridge Laboratories Ltd | Procter & Gamble Pharmaceuticals UK, Ltd |
| Cardinal Health U.K. 416 Ltd | Protherics PLC |
| Celltech Group PLC | Reckitt Benckiser Healthcare (UK) Ltd |
| Celltech Manufacturing Services Ltd | Rhodia Pharma Solutions Ltd |
| Cenes Pharmaceuticals PLC | Roche Products Ltd |
| Chiroscience R&D Ltd | Rosemont Pharmaceuticals Ltd |
| Co-Pharma Ltd | Sandoz Ltd |
| C P Pharmaceuticals Ltd | Sanofi-Synthelabo Ltd |
| Custom Pharmaceuticals Ltd | Schering-Plough Ltd |
| Dales Pharmaceuticals Ltd | Schwarz Pharma Ltd |
| Darwin Discovery Ltd | Serono Ltd |
| D.D.D. Ltd | Shire Pharmaceuticals Group PLC |
| Denfleet International Ltd | Sinclair Pharma PLC |
| E.C.De Witt & Co., Ltd | Skyepharma PLC |
| Diomed Developments Ltd | Stiefel Laboratories (U.K.) Ltd |
| Eli Lilly & Co. Ltd | Strakan Pharmaceuticals Ltd |
| Ferring Pharmaceuticals Ltd | Thornton & Ross Ltd |
| Fisons Ltd | Tocris Cookson Ltd |
| Forest Laboratories UK Ltd | Universal Products (Lytham) Manufacturing Ltd |
| Fresenius Kabi Ltd | Unomedical Ltd |
| Generics (U.K.) Ltd | Upstate Ltd. |
| Genzyme Ltd | Vitabiotics Ltd |
| Glaxosmithkline PLC | Westone Products Ltd |
| Glaxosmithkline UK Ltd | Wigmore Medical Ltd |
| Goldshield Pharmaceuticals Ltd. | William Ransom & Son PLC |
| Gowrie Ltd | Wrafton Laboratories Ltd |
| Hoechst Marion Roussel Ltd | Zyus Corporation Ltd |
| Imperial Pharmaceuticals Ltd | |
| John Wyeth & Brother Ltd | COMPANIES WITH INTERESTS IN PHARMACEUTICALS |
| Kent Pharmaceuticals Ltd | Abbott Laboratories Ltd |
| Kyowa Hakko U.K. Ltd | American Home Products Holdings (U.K.) Ltd |
| Lundbeck Pharmaceuticals Ltd | Amersham PLC |
| Macarthys Laboratories Ltd | Baxter Healthcare Ltd |
| Manx Healthcare Group Ltd | Bayer PLC |
| Mawdsley-Brooks & Co. Ltd | Carter Products Ltd |
| May & Baker Ltd | Ccl Industries (U.K.) Ltd |
| Meconic Ltd | Innovata Biomed Ltd |
| Medisys PLC | Mcbride PLC |
| Mentholatum Co. Ltd (The) | Oxford Glycosciences Ltd |
| Merck Ltd | Prova (R & D) Ltd |
| Merck Sharp & Dohme Ltd | Pz Cussons PLC |
| M.L. Laboratories PLC | Smith & Nephew PLC |
| Napp Pharmaceuticals Ltd | Weleda (U.K.) Ltd |
| Norgine Ltd | Xenova Biomedix Ltd |
EXECUTIVE SUMMARY
This Business Ratio report focuses on the leading 124 companies operating in the pharmaceutical manufacturers and developers industry. This summary brings you a sample of key details from this invaluable report. The report itself includes many further analyses of the performance of individual companies and the industry as a whole. The report analyses company and industry performance over the three years up to 7th June 2003. During this period, the average Report company has seen sales increase by 18.3 percent; from £502.5 million in 2000/01 to £594.3 million in 2002/03. Profits however witnessed a decline of two percent, from £145.9 million in the first year of analysis to £142.9 million in the final year
Profitability
Employee Performance
Top Ten Companies by Turnover
| Profit Margin | Asset Utilisation | Total Debt/Net Worth | Sales | ||||||||
| Company Name and | (%) | (%) | Growth | ||||||||
| Third Year Sales £ million | 02/03 | 01/02 | 00/01 | 02/03 | 01/02 | 00/01 | 02/03 | 01/02 | 00/01 | % | |
| Report Averages | 24.1 | 19.9 | 29.1 | 1.03 | 1 | 0.93 | 108.5 | 96.7 | 71.9 | 9 | |
| Glaxosmithkline PLC | 21212 | 26 | 22.1 | 33.4 | 0.96 | 0.92 | 0.84 | 99.7 | 77.4 | 62.9 | 8 |
| Astrazeneca PLC | 17841 | 22.7 | 25.2 | 21.3 | 0.83 | 0.88 | 0.99 | 10.5 | 16.1 | 17.4 | -1 |
| AAH Pharmaceuticals | 2761.9 | 6.2 | 6 | 5.7 | 3.72 | 4.53 | 3.69 | 12.1 | 5.5 | 76.8 | 8 |
| Eli Lilly & Co | 1126.2 | 19.6 | 18.4 | 19.2 | 1.37 | 1.43 | 1.33 | 123.7 | 138.5 | 186 | 19 |
| Pfizer | 948.4 | 72.3 | 36 | 56.1 | 0.53 | 0.51 | 0.55 | 281.6 | 817.5 | 135.1 | 12 |
| Shire Phrmctcls Gp. PLC | 712.5 | -73.9 | 14.1 | 22.4 | 0.23 | 0.16 | 0.35 | 38.9 | 57.3 | 72.2 | 44 |
| May & Baker | 622.2 | 11.8 | 9.5 | 3.6 | 0.81 | 0.82 | 0.8 | 1059.6 | ^ | ^ | 8 |
| John Wyeth & Brother | 545.3 | 8.5 | 11.7 | 8.4 | 1.96 | 1.8 | 2.7 | 76.7 | 133 | 120.9 | -4 |
| Merck Sharp & Dohme | 406.7 | 9.7 | -9.6 | -31 | 0.86 | 0.87 | 0.89 | 85.7 | 123.2 | 682.8 | 20 |
| Pharmacia | 396.4 | 10.2 | 10.7 | 4.8 | 0.93 | 0.86 | 0.44 | 707.5 | ^ | ^ | 36 |
Text © 2004 Prospect Swetenhams
| Can't find what you
need? Try our "Research on Request" market report service and define your own report research! Fixed prices - £150, £450 and £1,250 - and fixed delivery of 4, 5 and 14 days |
| Click here for full details |
Ariadne - working together with our customers
to enhance productivity and increase knowledge
© 2004
www.the-list.co.uk Ariadne
Last updated by Amanda Porteous February 2004